Figure 4.
OS by randomization in the genomic subgroups. (A) MDS-related cytogenetic abnormalities, (B) MDS-related gene mutations, and (C) TP53 mutation.

OS by randomization in the genomic subgroups. (A) MDS-related cytogenetic abnormalities, (B) MDS-related gene mutations, and (C) TP53 mutation.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal